Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Movicol in IBS-C
NCT00796354Phase 3Completed
- Sponsor
- Norgine
- Start
- Nov 2008
- Primary completion
- Feb 2010
- Modality
- Polymer-based Nanoparticles
- Countries
- 7
01
Overview
A Phase 3 trial of polyethylene glycol in irritable bowel syndrome (IBS), sponsored by Norgine. Started Nov 2008; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00796354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796354.